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Objectives. This study is aimed at identifying the best clinical model to predict poststroke independence at 6 and 18 months,
considering sociodemographic and clinical characteristics, and then identifying differences between countries. Methods. Data
was retrieved from the International Stroke Trial 3 study. Nine clinical variables (age, gender, severity, rt-PA, living alone, atrial
fibrillation, history of transient ischemic attack/stroke, and abilities to lift arms and walk) were measured immediately after the
stroke and considered to predict independence at 6 and 18 months poststroke. Independence was measured using the Oxford
Handicap Scale. The adequacy, predictive capacity, and discriminative capacity of the models were checked. Countries were
added to the final models. Results. At 6 months poststroke, 35.8% (n = 1088) of participants were independent, and at 18
months, this proportion decreased to 29.9% (n = 747). Both 6 and 18 months poststroke predictive models obtained fair
discriminatory capacities. Gender, living alone, and rt-PA only reached predictive significance at 18 months. Poststroke patients
from Poland and Sweden showed greater chances to achieve independence at 6 months compared to the UK. Poland also
achieved greater chances at 18 months. Italy had worse chances than the UK at both follow-ups. Discussion. Six and eight
variables predicted poststroke independence at 6 and 18 months, respectively. Some variables only reached significance at 18
months, suggesting a late influence in stroke patients’ rehabilitation. Differences found between countries in achieving
independence may be related to healthcare system organization or cultural characteristics, a hypothesis that must be addressed
in future studies. These results can allow the development of tailored interventions to improve the outcomes.
1. Introduction
Stroke is a worldwide problem with an increasing number of
cases [1]. Every year, about 16 million people are affected for
the first time by a stroke, of which 5.7 million die [2]. The
number of individuals affected by a stroke is increasing over
the years, due to population ageing. It was estimated that
1.1 million strokes occurred in 2000 and 13.7 million in
2016 [3]. Recent projections estimated that by 2030, around
77 million strokes will occur worldwide [2, 4]. Brain dis-
eases are the major contributors to the burden associated
with morbidity in Europe, with stroke being the 4th most
influential disease [5].
Achieving functional independence is one of the main
goals for all those involved with individuals that suffered a
stroke [6, 7]. The impact of the dependent person due to
stroke goes far beyond their functional activities, including
costs of care borne by governments and the burden for family
members or caregivers. Often, these are not only responsible
for direct assistance in the physical activities of daily life but
also for the management of the various biopsychosocial
dimensions of the person with stroke [8]. Prediction of func-
tional independence poststroke is mainly based on instru-
ments as Barthel Index and Functional Independence
Measure, rating functional independence in specific activities
of daily-living (ADL) as feeding, grooming, or toileting [9].
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However, the Oxford Handicap Scale (OHS) is a generic
instrument related to overall independence and overall dis-
ability in life, which tries to differentiate an independent per-
son from a dependent person [10]. This scale is aimed at
assessing the general level of handicap of the respondent in
his/her lifestyle and that may state different outcomes from
the functional independence measures reported.
The European Stroke Organization action plan between
2018 and 2030 considers poststroke rehabilitation an impor-
tant target [11]. Rehabilitation is instrumental in enabling
people with functional limitations to remain in or return to
their home or community, live independently, and partici-
pate in education, work, and civic life. Yet, it is expected that
functional status of independence status 3-6 months after
stroke does not change considerably in a large proportion
of individuals, even though transitions between (ADL) inde-
pendence and dependency can occur up to 5 years after
stroke [12]. So, most patients may have discharged from unit
cares to community care 6 months after stroke and other
factors beyond age and severity may also influence the inde-
pendence transitions [13, 14].
In addition to the clinical and inherent factors of the indi-
vidual, there are potential differences in content and organi-
zational aspects of rehabilitation between national or
regional systems that may facilitate or prevent the enhance-
ment of the independence of poststroke individuals in the
community after months or years [15]. For example, patients
in low-income and middle-income countries have poorer
access to stroke services, which may leads to lower access to
other rehabilitation services and higher survival rates with
severe dependency [16]. Also, a lack of clinical guidelines to
aid clinical decision-making about access to stroke rehabilita-
tion lead to subjective approaches by patient-level and orga-
nizational factors alongside clinicians’ characteristics across
services and countries [17]. The process of care involved in
patient’s reintegration from hospital to the community
(rehabilitation and general practice) is frequently unsuccess-
ful, regardless of the country. Nevertheless, since the profes-
sional hierarchy of stroke teams varies with the national
context, healthcare systems may also differ on the provided
treatments and in the clinical pathways for the transition to
the community [16].
The development of medium/long-term models of inde-
pendence prognosis can assist clinicians in adapting rehabil-
itation, referral, and discharge planning for poststroke users,
reducing health-related costs and the associated economic
impact [18–20]. Factors such as age and poststroke severity
are well known as predictors of functional status and, there-
fore, patient’s independence [19, 21]. The size of the vascular
lesion, the presence of atrial fibrillation, the ability to walk,
and the functional state before the stroke have also been
included in some studies [21]. Predictors of functionality
and mortality in individuals affected by a stroke have the
attention of researchers since the 1980s, with a substantial
increase in the number of related studies [22]. By 2018, more
than 195 predictive variables have been identified for post-
stroke functional recovery, and at least more than 63 multi-
variate models of functionality prognosis have been found
[9, 23]. However, choosing a specific prognostic model
remains a controversial topic, since there is hardly a single
model for all situations, subgroups, or times of assessment.
It is essential, as early as possible, to predict which factors
are associated with a greater chance of independence in the
medium and long term, to allocate personalized resources
for each subgroup. Furthermore, the odds of obtaining inde-
pendence could be different among countries due to their dif-
ferent healthcare systems and rehabilitation methods.
However, the literature is scarce regarding differences between
countries and long-term predictors of independence.
Hence, this study is aimed at identifying the best clinical
model to predict poststroke independence at 6 and 18
months, considering sociodemographic and clinical charac-
teristics, and then identifying differences between countries.
2. Methods
2.1. Sample and Design of the Original Study. The informa-
tion used for analysis was obtained from the database pro-
vided by the study “International Stroke Trial-3” (IST-3)
[24], a resource provided to carry out secondary analyzes
[25]. The original study was a randomized controlled multi-
center study that collected information from 3035 subjects
with ischemic stroke, in 156 centers in 12 different countries
between 2000 and 2015. The primary objective of IST-3 was
to verify whether the administration of activator of recombi-
nant intravenous tissue plasminogen (rt-PA) increased the
proportion of independent persons at 6 months, in the inter-
vention group. Additionally, follow-ups were also performed
at 18 months poststroke. All methods and procedures used
for data collection can be accessed in the IST-3 protocol
[24]. Briefly, the selection criteria for integration in the study
were having symptoms and clinical signs of acute stroke, pre-
cise knowledge of when the stroke appeared, the possibility of
starting treatment for thrombolysis in the first 6 hours after
the onset of the stroke, and guarantee of the reliability of
computed tomography (CT) or magnetic resonance (MR)
to exclude intracranial hemorrhages or structural brain inju-
ries that could mimic a stroke. CT and MRI were performed
before the randomization of the participants and repeated 24
and 48 hours after the occurrence of the stroke, which can
also be repeated if there was suspicion of neurological deteri-
oration in the first 7 days. The sample size of the study was
recalculated in 2007 for 3100, which gave 80% power to
detect an absolute difference of 4.7% in the primary outcome
[26]. The protocol was approved by the Multicenter Research
Ethics Committees, Scotland (MREC/99/0/78), and by local
ethics committees in 30 centers in different countries.
2.2. Definition of Variables. The outcome variable is “Inde-
pendence” at 6 and 18 months. In the IST-3 study, the
Oxford Handicap Score (OHS) scale of 6 scoring levels was
used to measure the degree of independence at 7 days, 6
and 18 months after the stroke, which is an autoreported
scale variant of the modified Rankin scale commonly used
[10]. Scores between 0 and 2 on the OHS scale were recoded
to categorize the event as “Independent” and between 3 and 5
as “dependent.” [27, 28] Scores of 6 (“Death”) were excluded
from the analysis. The clinical covariables collected in the
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baseline (recorded up to a maximum of 6 hours immediately
after the onset of stroke symptoms) were classified as age
(categorized in classes of 10 years), gender (male/female),
previous history of transient ischemic attack/stroke (yes/no),
atrial fibrillation (yes/no), living alone before the stroke
(yes/no), degree of severity immediately after the stroke
through the scale National Institutes of Health Stroke Scale
(NHISS) (classified as 1-4 mild, 5-15 mild to moderate, 16-
20 mild, 21-42 severe), stroke subtype (anterior total circula-
tion strokes (TACI), anterior partial circulation strokes
(PACI), lacunar infarcts (LACI), posterior circulation infarc-
tions (POCI), or others), intervention with rt-PA (yes/no),
ability to raise both upper limbs (yes/no), and ability to walk
alone (yes/no). Previous state of independence was not
included because more than 99.9% were independent. Finally,
a geodemographic variable was also included, relative to the
country where the subject was hospitalized. Collaborating
countries were Austria, Australia, Belgium, Canada, Italy,
Mexico, Norway, Poland, Portugal, Sweden, Switzerland, and
UK (Austria, Canada, Mexico, and Switzerland data were
grouped to “Others,” due to the low number of participants).
2.3. Data Analysis. Descriptive analysis was performed
through absolute and relative frequencies. Due to the high
number of dropouts between 6 and 18 months, the answers
between those who completed the questionnaires up to 18
months and 6 months were compared. All categorical covar-
iates were tested using the chi-square test (results in Table 1)
[29]. A statistical significance of p < 0:05 was considered for
every analysis.
The odds ratio (OR) and respective confidence intervals
(CI) of all clinical covariates were estimated for the subject’s
independence at 6 and 18 months, individually, through
bivariate logistic regression (RL), for a descriptive purpose
only (results on Table 2).
The model was developed in several steps. First, all covar-
iates were adjusted for age and severity due to their clinical
relevance for the outcome [9, 30]. Gender was not adjusted
to the model since it was not associated with poststroke inde-
pendence in a systematic review [9]. Finally, an automatic
stepwise regression procedure was used, using the forward
LR selection method [29], to select statistically significant
variables, after adjustment for age and severity, for 6 and 18
months (considering exclusion criteria p > 0:10). Odds ratio
with 95% CI was used as the measure of association. The
adequacy and predictive capacity of the models were assessed
using the Hosmer-Lemeshow adjustment test, the
Nagelkerke R2 test, and the area under the curve (AUC) of
receiver operation characteristic (ROC) [29].
To ascertain differences between countries, the geograph-
ical variable was added to the final predictive models. The UK
was used as the class reference since it is the country with a
higher number of participants. The adequacy and predictive
capacity of the model were then rechecked.
3. Results
A total of 3035 subjects, most with ages between 71 and 90
years old (70.3%), were included in the analysis, with 51.7%
(n = 1570) being male. The characteristics of the sample are
described in Table 3.
At 6 months 35.8% (n = 1088) of the participants were
independent, 37.3% (n = 1132) were dependent, and 815 died
(26.9%). There were no dropouts. At 18 months, 17.6%
(n = 533) people were lost to follow-up and 35.4% (n = 1075)
died. The proportion of independents decreased to 29.9%
(n = 747) and dependents to 22.4% (n = 680). Of those who
completed follow-up at 18 months, about 5.7% (n = 82) were
dependent at 6 months and became independent, and the
reverse was observed in 8.3% (n = 119).
The transitions of functional independence status from 6
to 18 months can be seen in Figure 1.
Table 1 presents the comparison between all valid
answers at 18 months and the baseline sample (or 6 months,
once there were no dropouts at this follow-up). We found a
difference in the distribution of responses for the variable
countries (p value ≤ 0.01) and “Able to lift both upper arms”
(p value = 0.04) among the two samples.
Bivariate analysis for each clinical covariate related to
independence can be found in Table 2.
In Table 4, we can see the multivariate analysis of each
clinical covariate adjusted for age and severity at 6 and 18
months: gender, living alone, and intervention with rt-PA
were not identified as statistical predictors of independence
at 6 months but were statistically significant at 18 months.
3.1. A Predictive Model of Poststroke Independence at 6
Months and 18 Months. Table 5 shows final prediction
models for independence at 6 months and 18 months.
At 6 months, six subjects (<0.1% relative to the baseline
sample) were excluded from the analysis due to incomplete
data (5 lacked information on the previous history of
TIA/CVA, and one was excluded for being the only patient
with NHISS value = 0). Gender, living alone, and interven-
tion rt-PA were not included in the final model because they
have not reached statistical significance in the analysis
adjusted to age and severity (Table 4). Atrial fibrillation was
the only variable ruled out in the final model.
This model was adequate, fitted to Hosmer-Lemeshow
test (p = 0:965), and with fair discrimination (0.307 for
Nagelkerke, AUC = 0:782).
At 18 months, from the initial sample, 539 subjects
(17.8% relative to the baseline sample) were excluded from
the analysis due to missing data in some variables. Except
for the previous history of TIA/CVA, all other variables were
statistically significant when adjusted to age and severity
(Table 4) and therefore included in the final model. Similar
to the model for 6 months, only atrial fibrillation was
excluded in the final model.
This model was adequate, fitted to Hosmer-Lemeshow
test (p = 0:789), and with fair discrimination (0.294 for
Nagelkerke, AUC = 0:774).
In both final models at 6 and 18 months after stroke, age
and NHISS have an OR above 6 (although the CI has a large
amplitude, which makes the point estimate imprecise).
3.2. Relationship of Countries in Predicting Poststroke
Independence. Table 6 presents the results of the addition of
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Table 1
Characteristics of sample participants vs. sample at 18 months Baseline sample 3035, n (%) 18 months 2502, n (%) p value
Age
0.95
18-50 127 (4.2%) 93 (3.7%)
51-60 202 (6.7%) 159 (6.4%)
61-70 365 (12.0%) 306 (12.2%)
71-80 724 (23.9%) 596 (19.6%)
81-90 1407 (46.4%) 1170 (46.8%)
> 91 210 (6.9%) 178 (7.1%)
NHISS
0.35
0 (no clinical signs) 1 (0.1%) 1 (0.1%)
1-4 (light) 399 (13.1%) 306 (12.2%)
5-15 (mild to moderate) 1665 (54.9%) 1341 (53.6%)
16-20 (moderate) 543 (17.9%) 476 (19.0%)
21-42 (severe) 427 (14.1%) 378 (15.1%)
Stroke subtype
0.47
TACI 1306 (43.0%) 1129 (45.1%)
PACI 1146 (37.8%) 913 (36.5%)
LACI 332 (10.9%) 275 (11.0%)
POCI 246 (8.1%) 180 (7.2%)
Other 5 (0.2%) 5 (0.2%)
Lived alone before the stroke
0.73Yes 1129 (37.2%) 942 (37.6%
No 1906 (62.8%) 1560 (62.4%)
Previous history of TIA/stroke
0.81
Yes 699 (23.0%) 583 (23.3%)
No 2331 (76.8%) 1914 (76.5%)
Unknown 5 (0.2%) 5 (0.2%)
Atrial fibrillation
0.49Yes 914 (30.1%) 755 (31.0%)
No 2121 (69.9%) 1727 (69.0%)
Intervention
0.93rt-PA 1515 (49.9%) 1246 (49.8%)
Control 1520 (50.1%) 1256 (50.2%)
Able to raise both arms
0.04Yes 1351 (44.5%) 1044 (41.7%)
No 1684 (55.5%) 1458 (58.3%)
Able to walk without help
0.14Yes 487 (16.0%) 365 (14.6%)
No 2548 (84.0%) 2137 (85.4%)
Country
<0.01
Australia 179 (5.9%) 177 (7.1%)
Belgium 73 (2.4%) 70 (2.8%)
Italy 326 (10.7%) 236 (9.4%)
Norway 204 (6.7%) 199 (8.0%)
Others∗ 80 (8.4%) 58 (2.3%)
Poland 347 (11.4%) 306 (12.2%)
Portugal 82 (2.7%) 38 (1.5%)
Sweden 297 (9.8%) 296 (11.8%)
United Kingdom 1447 (47.7%) 1122 (44.8%)
NHISS: National Institutes of Health Stroke Scale; TACI: strokes of the anterior total circulation; PACI: infarctions of anterior partial circulation; LACI: lacunar
infarcts; POCI: posterior circulation strokes; TIA/AVC: transient ischemic attack/stroke; rt-PA: recombinant intravenous tissue plasminogen activator. ∗
Others—including Austria, Canada, Mexico, and Switzerland.
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the variable “Countries” as a predictor for independence in
the final models.
All the covariables added in the final models with coun-
tries remained statistically significant after the inclusion of
countries, except for “Living Alone” at 18 months. Models
at 6 and 18 months showed good values at the Hosmer-
Lemeshow tests (p = 0:955 and p = 0:784, respectively),
Nagelkerke (0.322 and 0.308, respectively), and fair discrim-
ination values in AUC (0.789 and 0.781, respectively).
4. Discussion
The purposes of this study were to create the best predictive
models with available variables to identify differences
Table 2: Predictors for independence at 6 and 18 months poststroke, with OR and 95% CI.







Age (reference class: >91) <0.01 <0.01
18-50 7.35 (4.06–14.00) <0.01 5.49 (2.51-12.02) <0.01
51-60 5.71 (3.34-9.77) <0.01 5.10 (2.47-10.53) <0.01
61-70 4.22 (2.56-6.94) <0.01 3.52 (1.78-6.97) <0.01
71-80 2.76 (1.72-4.44) <0.01 2.07 (1.07-4.01) 0.03
81-90 2.11 (1.33-3.35) <0.01 1.83 (0.95 – 3.51) 0.07
Gender (reference class: female)
Male 1.55 (1.31-1.83) <0.01 1.72 (1.40-2.13) <0.01
NHISS (reference class: severe (21–42)) <0.01 <0.01
Mild (1–4) 34.46 (20.46-58.03) <0.01 21.93 (11.51-41.80) <0.01
Moderate (5–14) 7.02 (4.55-11.40) <0.01 6.32 (3.52-11.35) <0.01
Moderate to severe (15–20) 2.00 (1.18-3.35) 0.09 1.50 (0.77-2.92) 0.23
Previous TIA/stroke history (reference class: yes)
No 1.28 (1.05-1.57) 0.02 1.41 (1.14-1.75) <0.01
Stroke subtype (reference class: TACI) <0.01 <0.01
PACI 3.62 (2.94-4.45) <0.01 3.09 (2.4-4.00) <0.01
LACI 5.41 (4.06-7.20) <0.01 5.64 (3.96-8.02) <0.01
POCI 6.12 (4.38-8.55) <0.01 5.16 (3.38-7.87) <0.01
Other 4.12 (0.68-24.81) 0.12 3.40 (0.562-20.59) 0.18
Lived alone before the stroke (reference class: no)
Yes 1.02 (0.86-1.22) 0.80 0.94 (0.76-1.17) 0.60
Intervention with rt-PA (reference class: no)
Yes 1.09 (0.92-1.28) 0.33 1.25 (1.01-1.54) 0.04
Atrial fibrillation (reference class: yes)
No 1.80 (1.48-2.19) <0.01 1.92 (1.49-2.47) <0.01
Able to lift both upper limbs (reference class: no)
Yes 4.52 (3.78-5.41) <0.01 4.15 (3.32-5.17) <0.01
Able to walk without help (reference class: no)
Yes 5.21 (4.08-6.65) <0.01 4.06 (3.04-5.43) <0.01
Country (Reference class: UK)
Australia 1.14 (0.79-1.65) 0.48 0.97 (0.65-1.46) 0.88
Belgium 1.42 (0.81-2.48) 0.22 1.74 (0.92-3.28) 0.08
Italy 0.99 (0.75-1.31) 0.95 0.78 (0.54-1.11) 0.17
Norway 1.38 (0.99-1.94) 0.06 1.49 (1.02-2.17) 0.04
Others∗ 2.18 (1.26-3.81) <0.01 1.14 (0.55-2.37) 0.73
Poland 3.05 (2.28-4.08) <0.01 2.92 (2.04-4.16) <0.01
Portugal 0.71 (0.41-1.24) 0.23 0.57 (0.14-2.30) 0.43
Sweden 1.66 (1.25-2.20) <0.01 1.51 (1.10-2.08) 0.01
NHISS: National Institutes of Health Stroke Scale; TACI: strokes of the anterior total circulation; PACI: infarctions of anterior partial circulation; LACI: lacunar
infarcts; POCI: posterior circulation strokes; TIA/AVC: transient ischemic attack/stroke; rt-PA: recombinant intravenous tissue plasminogen activator. ∗
Others—including Austria, Canada, Mexico, and Switzerland.
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Table 3: Characteristics of the survival participants.
Baseline Sample (N = 3035), n (%) 6 months (n = 2220), n (%) 18 months (n = 1427), n (%)
Independence Dependence Independence Dependence
Age
18-50 127 (4.2%) 88 (69.3%) 35 (27.6%) 62 (66.7%) 25 (26.9%)
51-60 202 (6.7%) 125 (61.9%) 64 (31.7%) 99 (62.3%) 43 (27.0%)
61-70 365 (12.0%) 186 (51.0%) 129 (35.3%) 148 (48.4%) 93 (30.4%)
71-80 724 (23.9%) 278 (38.4%) 294 (40.6%) 185 (31.0%) 198 (33.2%)
81-90 1407 (46.4%) 385 (27.4%) 534 (38.0%) 239 (20.4%) 290 (24.8%)
> 91 210 (6.9%) 26 (12.4%) 76 (36.2%) 14 (7.9%) 31 (17.4%)
NHISS
0 (no clinical signs) 1 (0.1%) — — — —
1-4 (mild) 399 (13.1%) 313 (78.4%) 64 (16.0%) 217 (70.9%) 53 (17.3%)
5-15 (mild to moderate) 1665 (54.9%) 684 (41.1%) 669 (40.2%) 474 (35.3%) 402 (30.0%)
16-20 (moderate) 543 (17.9%) 69 (12.7%) 244 (44.9%) 42 (8.8%) 150 (31.5%)
21-42 (severe) 427 (14.1%) 22 (5.2%) 155 (36.3%) 14 (3.7%) 75 (19.8%)
Gender
Female 1570 (51.7%) 474 (30.2%) 616 (39.2%) 312 (24.0%) 376 (28.9%)
Male 1465 (48.3%) 614 (41.9%) 516 (35.2%) 435 (36.2%) 304 (25.3%)
Stroke subtype
TACI 1306 (43.0%) 203 (15.5%) 557 (42.6%) 138 (12.2%) 313 (27.7%)
PACI 1146 (37.8%) 534 (46.6%) 405 (35.3%) 356 (39.0%) 261 (28.6%)
LACI 332 (10.9%) 203 (61.1%) 103 (31.0%) 159 (57.8%) 64 (23.3%)
POCI 246 (8.1%) 145 (58.9%) 65 (26.4%) 91 (50.6%) 40 (22.2%)
Other 5 (0.2%) 3 (60%) 2 (40.0%) 3 (60%) 2 (40.0%)
Lived alone before the stroke
Yes 1129 (37.2%) 396 (35.1%) 418 (37.0%) 278 (29.5%) 244 (25.9%)
No 1906 (62.8%) 692 (36.3%) 714 (37.5%) 469 (30.1%) 436 (27.9%)
Previous history of TIA/stroke
Yes 699 (23.0%) 214 (30.6%) 271 (38.8%) 143 (24.5%) 159 (27.3%)
No 2331 (76.8%) 872 (37.4%) 860 (36.9%) 602 (31.5%) 521 (27.2%)
Unknown 5 (0.2%) — — — —
Atrial fibrillation
Yes 914 (30.1%) 212 (23.2%) 343 (37.5%) 130 (16.8%) 196 (25.3%)
No 2121 (69.9%) 876 (41.3%) 789 (37.2%) 617 (35.7%) 484 (28.0%)
Intervention
rt-PA 1515 (49.9%) 554 (36.6%) 553 (36.5%) 393 (31.5%) 320 (25.7%)
Control 1520 (50.1%) 534 (35.1%) 579 (38.1%) 354 (28.2%) 360 (28.7%)
Able to raise both arms
Yes 1351 (44.5%) 778 (57.6%) 404 (29.9%) 524 (50.2%) 246 (23.6%)
No 1684 (55.5%) 310 (18.4%) 728 (43.2%) 223 (15.3%) 434 (29.8%)
Able to walk without help
Yes 487 (16.0%) 357 (73.3%) 97 (19.9%) 240 (65.8%) 71 (19.5%)
No 2548 (84.0%) 731 (28.7%) 1035 (40.6%) 507 (23.7%) 609 (28.5%)
Country
Australia 179 (5.9%) 60 (33.5%) 69 (38.5%) 52 (29.4%) 61 (34.5%)
Belgium 73 (2.4%) 27 (37.0%) 25 (34.2%) 26 (37.1%) 17 (24.3%)
Italy 326 (10.7%) 111 (34.0%) 147 (45.1%) 64 (27.1%) 94 (39.8%)
Norway 204 (6.7%) 80 (39.2%) 76 (37.3%) 77 (38.7%) 59 (29.6%)
Others∗ 80 (2.6%) 35 (43.8%) 21 (26.3%) 15 (25.9%) 15 (25.9%)
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between countries for poststroke independence in alive
patients. In this study, we developed predictive models for
poststroke subject’s independence at 6 and 18 months, based
on clinical characteristics collected within 6 hours after the
stroke. Age, severity, stroke subtype, ability to raise both
arms, and ability to walk were predictors for poststroke inde-
pendence at both follow-ups. The previous history of TIA/s-
troke was also for independence at 6 months after stroke. On
the other hand, living alone before stroke, rt-PA intervention,
and gender were also predictors of independence in the final
model 18 months after stroke. Considering countries, Poland
had more chances for achieving independence after the
stroke compared to the UK at 6 and 18 months after stroke,
Sweden also but only at 6 months (although IC95% at 18
months is suggestive to be explored in other future studies),
and Italy demonstrated fewer chances of achieving indepen-
dence at 6 and 18 months after stroke.
Age, severity (measured by NHISS), and subtype were
predictive of poststroke independence both at 6 and 18
months. These characteristics are usually found in predictive
models and are well accepted as explaining the success/fai-
lure for functional recovery [23]. Age and severity were
described as the main factors in predicting functionality in
the literature [9]. Other factors found in our analysis, such
as the history of TIA/stroke, raising both arms of the bed,
and walking alone, are also described in the literature [9,
31], but less frequently achieves statistic relevance when
modelled with other variables such as age and severity [32].
In our study, gender, rt-PA intervention, and living alone
before stroke were not statistically significant in the final
model at 6 months, but at 18 months. In some studies [33,
34], females appeared to have worse functional outcomes
after stroke; however, gender is not included in many predic-
tive models in the literature and its relevance is not consen-
sual [23]. Our analysis found that gender may influence
independence poststroke only 18 months after the event
but not at 6, which may contribute to the controversy found
in literature, although at 18 months we also found worse
changes for women to achieve independence. There is some
controversy regarding the predictive impact of the interven-
tion, rt-PA, which has been associated with better outcomes
of survival at early stages, at longer stages [32, 35, 36]. Simi-
larly, to our results, other studies found no statistical associ-
ation for this intervention in predicting functionality at 6
months [32]. Thus, predictive relevance found in our study
only at 18 months may be an important indicator when
considering future research with rt-PA, not only to predict
survival or short-term independence [30] but also for long-
term independence. This may be an important finding since
some countries still struggle with its implementation [37].
A study [31] found no relationship between poststroke inde-
pendence and living alone at 3 and 12 months, although this
Table 3: Continued.
Baseline Sample (N = 3035), n (%) 6 months (n = 2220), n (%) 18 months (n = 1427), n (%)
Independence Dependence Independence Dependence
Poland 347 (11.4%) 186 (53.6%) 80 (23.1%) 141 (46.1%) 55 (18.0%)
Portugal 82 (2.7%) 20 (24.4%) 37 (45.1%) 3 (7.9%) 6 (15.8%)
Sweden 297 (9.8%) 134 (45.1%) 106 (35.7%) 122 (41.2%) 92 (31.1%)
United Kingdom 1447 (47.7%) 435 (30.1%) 572 (39.5%) 247 (22.0%) 281 (25.0%)
NHISS: National Institutes of Health Stroke Scale; TACI: strokes of the anterior total circulation; PACI: infarctions of anterior partial circulation; LACI: lacunar
infarcts; POCI: posterior circulation strokes; TIA/AVC: transient ischemic attack/stroke; rt-PA: recombinant intravenous tissue plasminogen activator. ∗
Others: Austria, Canada, Mexico, and Switzerland were grouped into one group due to their small number of participants.
Baseline
N = 3035
Alive = 1427Alive = 2220
Total deaths = 815
Independent = 1088 (49.0%)
Independent = 665 (61.1%)
Independent = 82 (7.2%)
Dependent = 119 (10.9%)
Dependent = 561 (49.6%)
Dead = 211 (18.6%)
Total deaths = 1075
Missings = 278 (24.6%)
Dead = 49 (4.5%)
Missings = 255 (23.4%)
Dependent = 1132 (51.0%)
6 months 18 months
Figure 1: Baseline (n = 3035), 6 months (n = 3035), and 18 months (n = 2502).
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variable is not taken into account in several prediction
models analyzed in a systematic review [9]. However, studies
from Craig et al. and Rejnö et al. found contradictory odds
favouring better functional outcomes for individuals living
alone in a range of time between 72 hours and 5 years of
follow-up, being the longest follow-up negatively related to
living alone [12, 38]. We found a positive association between
living alone and independence achievement at 18 months,
which may suggest that a set of experiences functioning alone
may help the individual to regain independence more effec-
tively in the long term.
Determining chances for recovery of independence pro-
vide levels of specificity and expectations for health profes-
sionals involved in the rehabilitation of poststroke users,
Table 4: Predictors for independence at 6 and 18 months poststroke adjusted for age and severity, with OR and 95% CI.







Age (reference class: >91) <0.01 <0.01
18-50 6.48 (3.43-12.26)a) <0.01 6.17 (2.65-14.38)a) <0.01
51-60 4.18 (2.35-7.42)a) <0.01 4.94 (2.28-19.71)a) <0.01
61-70 3.19 (1.87-5.44)a) <0.01 3.47 (1.67-7.19)a) <0.01
71-80 2.45 (1.48-4.06)a) <0.01 2.26 (1.11-4.58)a) 0.02
81-90 1.86 (1.14-3.05)a) 0.01 1.94 (0.97-3.89)a) 0.06
Gender (reference class: female)
Male 1.14 (0.95-1.38) 0.17 1.4 (1.07-1.72) 0.01
NHISS (reference class: severe (21–42)) <0.01 <0.01
Mild (1–4) 30.81 (18.20-52.15)b) <0.01 20.24 (10.53-38.91)b) <0.01
Moderate (5–14) 6.91 (4.35-10.99)b) <0.01 6.18 (3.41-11.20)b) <0.01
Moderate to severe (15–20) 1.90 (1.12-3.12)b) 0.02 1.40 (0.71 - 2.75)b) 0.33
Previous TIA/stroke history (reference class: yes)
No 1.22 (0.97-1.53) 0.08 1.17 (0.88-1.55) 0.27
Stroke subtype (reference class: TACI) <0.01 <0.01
PACI 1.75 (1.38-2.23) <0.01 1.58 (1.19-2.13) <0.01
LACI 1.98 (1.43-2.75) <0.01 2.28 (1.53-3.39) <0.01
POCI 2.23 (1.53-3.25) <0.01 2.00 (1.25-3.20) <0.01
Other 0.52 (0.08 - 3.31) 0.49 0.56 (0.09-3.62) 0.54
Lived alone before the stroke (reference class: no)
Yes 1.12 (0.92-1.36) 0.27 1.26 (0.99-1.61) 0.06
Intervention with rt-PA (reference class: no)
Yes 1.14 (0.95-1.38) 0.16 1.38 (1.10-1.74) <0.01
Atrial fibrillation (reference class: yes)
Not 1.23 (0.99-1.54) 0.07 1.33 (1.00-1.76) 0.05
Able to lift both upper limbs (reference class: no)
Yes 2.45 (1.97-3.04) <0.01 2.34 (1.79-3.06) <0.01
Able to walk without help (reference class: no)
Yes 2.52 (1.93-3.30) <0.01 2.04 (1.48-2.83) <0.01
Country (reference class: UK)
Australia 1.13 (0.79-1.70) 0.55 0.93 (0.59-1.45) 0.74
Belgium 1.01 (0.54-1.90) 0.97 1.11 (0.56-2.21) 0.77
Italy 0.77 (0.57-1.04) 0.09 0.66 (0.45-0.99) 0.04
Norway 1.35 (0.93-1.95) 0.12 1.51 (1.00-2.29) 0.05
Others 2.04 (1.11-3.76) 0.02 1.06 (0.47-2.39) 0.89
Poland 2.11 (1.53-2.92) <0.01 2.01 (1.36-2.98) <0.01
Portugal 0.71 (0.50-1.72) 0.82 1.04 (0.23-4.78) 0.96
Sweden 1.57 (1.14-2.17) <0.01 1.54 (1.07-2.22) 0.02
NHISS: National Institutes of Health Stroke Scale; TACI: strokes of the anterior total circulation; PACI: infarctions of anterior partial circulation; LACI: lacunar
infarcts; POCI: posterior circulation strokes; TIA/AVC: transient ischemic attack/stroke; rt-PA: recombinant intravenous tissue plasminogen activator; OR:
odds ratio; CI: confidence interval. ∗Adjusted to age and NHISS. a)Odds ratio adjusted to NHISS. b)Odds ratio adjusted to age.
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after validation. It is an important contributor for anticipat-
ing the schedule of rehabilitation and/or social integration
services, individually. Early prediction of long-term care
levels may lead to early supported discharge, improve the
efficiency of stroke management, and assist in healthcare
planning [39]. To our knowledge, this study used an uncom-
mon combination of variables to predict overall indepen-
dence at 18 months, since most models use functional
independence criteria over generic independence, measured
by OHS. Previous studies [32, 40–42] found predictive
models with discriminative capacities ranging from 0.79 to
0.90 AUC for 6 months. Thus, the model’s value obtained
in our study (AUC = 0:78) is lower than these values found
in the literature, but none of those studies were multicentric
or had more than one country participating. In an analysis
carried out based on the same individuals from the original
study, but with a much lower number of participants, the
AUC values were higher to those found in this study for 6
months but, despite using different variables such as being
independent before the stroke and the Glasgow scale, they
also divided the analysis in being alive and independent vs.
being alive and dependent or being dead, which was different
from our study, that only considered alive patients [43]. For
18 months poststroke, no studies were found to predict inde-
pendence, as longer follow-ups for this outcome (apart from
functionality) do not abound in the literature [44]. The clos-
est study found for 12 months after a stroke involving more
than one country found a model with an AUC of 0.88;
however, this study included several types of stroke (hemor-
rhagic/ischemic), not just ischemic [31].
As found in the patients in this study, bidirectional tran-
sitions of independence may occur in some cases over time. It
is known that physical therapy, 6 months after stroke, may
not inflict more independence than before [45]. Anyways,
the type of physical therapy intervention may be important
in changing these results. One study found that users who
were independent at 3 months poststroke can become depen-
dent within one year, an overall deterioration rate of this
transition of 3% a year [12]. Factors such as age, NIHSS score
at baseline, diabetes, and self-perceived unmet care needs
were related with patients transitions from ADL indepen-
dence to dependency 3 months after stroke and onwards,
Table 5: Final model for poststroke independence at 6 and 18 months.
6 months (n = 2217) 18 months (n = 1425)
OR (95% CI) p OR (95% CI) p
Age (reference: >91) <0.01 <0.01
18-50 5.65 (2.93-10.87) <0.01 6.42 (2.66-15.50) <0.01
51-60 3.99 (2.19-7.15) <0.01 4.90 (2.17-11.04) <0.01
61-70 3.01 (1.73-5.19) <0.01 3.50 (1.63-7.51) <0.01
71-80 2.34 (1.39-3.91) <0.01 2.35 (1.13-4.90) 0.02
81-90 1.71 (1.03-2.84) 0.04 1.89 (0.92-3.87) 0.08
Gender (reference: female)
Male — — 1.44 (1.13-1.85) <0.01
NHISS (reference: severe (21–42)) <0.01 <0.01
Mild (1–4) 7.33 (4.02-13.53) <0.01 5.27 (2.49-11.15) <0.01
Mild to moderate (5–15) 3.16 (1.92-5.20) <0.01 2.99 (1.59-5.64) <0.01
Moderate (16–20) 1.80 (1.06-3.05) 0.03 1.38 (0.70-2.73) 0.36
Stroke type (reference: TACI) <0.01 <0.01
PACI 1.44 (1.12-1.85) <0.01 1.30 (0.95-1.77) 0.10
LACI 2.03 (1.45-2.84) <0.01 2.28 (1.52-3.43) <0.01
POCI 1.76 (1.19-2.59) <0.01 1.61 (0.99-2.62) 0.06
Others 0.41 (0.06-2.96) 0.38 0.43 (0.06-3.04) 0.40
Previous history of TIA/stroke (reference: yes)
No 1.28 (1.02-1.61) 0.04 — —
Intervention (reference: no)
Yes — — 1.41 (1.11-1.79) <0.01
I lived alone before the stroke (reference: no)
Yes — — 1.33 (1.03-1.73) 0.03
Able to raise both arms (reference: no)
Yes 2.10 (1.67-2.63) <0.01 2.19 (1.65-2.91) <0.01
Able to walk without help (reference: no)
Yes 2.05 (1.54-2.72) <0.01 1.69 (1.19-2.39) <0.01
NHISS: National Institutes of Health Stroke Scale; TACI: strokes of the anterior total circulation; PACI: infarctions of anterior partial circulation; LACI: lacunar
infarcts; POCI: posterior circulation strokes; TIA/AVC: transient ischemic attack/stroke; OR: odds ratio; CI: confidence interval.
9Stroke Research and Treatment
while the opposite (from dependent to independent 3
months after stroke) was predicted by factors as living alone
before the stroke, being an ischemic stroke, and the severity
rated by NIHSS score at baseline. We can hypothesize that
dependent patients at 6 months undergo more therapy than
independent patients, which may contribute to their transi-
tion to independence at 18 months. Or the opposite, inde-
pendent patients at 6 months may leave the intervention
which contributed to that. However, given the aging of the
sample under study, the transition from independent states
to dependents is more easily understood, and the stroke
may or may not enhance this process.
Studies on differences between countries (or national
health systems) for predicting independence in the post-
stroke subject are scarce. The European Stroke Organization
is defined as a research priority the efficient implementation
of long-term rehabilitation strategies and improves participa-
tion and integration into society among stroke survivors [11].
At 6 months, between 10 and 26% of ischemic stroke survi-
vors in the UK and USA are expected to be institutionalized
into long care facilities [13]. In Poland, about 96.1% of stroke
survivors were at their home alone or with family at 6 months
and 95.6% at 18 months [14]. About 24.6% were in rehabili-
tation programs at 6 months and 19.3% were at 18 months.
This was similar to other studies in Sweden [46] with 92%
and 88% of stroke survivors living in their homes at 6 and
12 months and another [47] involving the UK and Australia,
where 75.3% of poststroke patients less than 65 years were
living at home at 12 months.
In our study, it seems that patients from Sweden and
Poland have greater chances to achieve independence at 6
months when compared with similar patients from the UK.
Individuals living in Poland had nearly two times more
chances of independence after a stroke than individuals liv-
ing in the UK. This difference might also be attributed to
healthcare organization and quality and not only to varia-
tions in age or severity. The Nordic countries are recognized
as having one of the best healthcare systems in the world,
with structural differences in stroke rehabilitation care,
incorporating multidisciplinary therapies after discussions
involving patients, families the medical team, and experts
[48, 49]. In a study considering 28 European countries, Italy
was the 4th country with the highest healthcare costs per per-
son who suffers a stroke, the UK was the 7th, Sweden was
below the top 10, and Poland was at 20th place [50]. In our
study, the chances to achieve independence after stroke in
each country are reverse to the economic government’s
health care investment, and this should be explored in future
studies. The effectiveness of different rehabilitation systems
should be investigated in different sociocultural contexts
and explore which particularities in each set may have a role
in achieving individual independence. Thereby, contributing
to cost-effectiveness programs which are important for eco-
nomic and public health development policies [50]. Coun-
tries with better chances of independence poststroke may
have similar characteristics that should be explored and
deeply understood, other than clinical variables, or direct
health care cost. Long-term rehabilitation has been
addressed as a vital issue in stroke needs across many coun-
tries in Europe [51], including the UK, but perhaps social
reintegration and rehabilitation programs after acute care
play a major role in the achievement of independence post-
stroke. Examples are the support offered by healthcare
systems to regain social participation [52] or return to work
[53]. Future studies should also investigate differences
between regional and national healthcare systems and
explore the factors for success.
The choice of the outcome variable requires some cau-
tion in its analysis. The OHS uses the term “handicap”
instead of “disability,” from the original scale, the modified
Rankin Scale. This was meant to include additional impor-
tant poststroke handicaps other than mobility [10]. Despite
being closely linked to the physical recovery of the post-
stroke subject, the scale’s score also reflects other dimen-
sions not directly related to physical or cognitive recovery,
such as the lifestyle and social dimension [10]. This predic-
tive study on independence differs from the majority of
other research found, where conceiving predictive models
poststroke were strictly based on functional independence
scales [23].
Table 6: Differences between countries in the final models.
6 months after stroke
OR adjusted (95% CI)∗
p
18 months after stroke




Australia 1.06 (0.70-1.62) 0.78 0.82 (0.51-1.31) 0.40
Belgium 0.82 (0.43-1.58) 0.55 0.98 (0.48-2.02) 0.96
Italy 0.71 (0.52-0.98) 0.04 0.64 (0.42-0.96) 0.03
Norway 1.33 (0.90-1.95) 0.15 1.46 (0.95-2.25) 0.09
Poland 1.96 (1.40-2.74) <0.01 1.82 (1.21-2.74) <0.01
Portugal 0.84 (0.44-1.61) 0.61 0.96 (0.20-4.64) 0.96
Sweden 1.44 (1.03-2.01) 0.03 1.39 (0.95-2.03) 0.09
Others∗∗ 1.70 (0.90-3.20) 0.10 0.77 (0.33-1.80) 0.56
OR: odds ratio; CI: confidence interval. ∗Used all the variables that were obtained in the respective final models. ∗∗Others—including Austria, Canada, Mexico,
and Switzerland.
10 Stroke Research and Treatment
Nevertheless, the uneven distribution of the sample
among the countries can strongly contribute to the lack of
significance of differences found with other countries so this
study should be replicated. Recent data should be collected to
ascertain whether these differences persist and explore possi-
ble reasons as to why this is happening, where qualitative
data could give more insights into other contextual factors
involved. Also, before clinical application, the proposed pre-
dictive models should be internally validated and replicated
in other independent samples (external validation) to verify
their suitability.
In the information collected through the database, one of
the factors that could be relevant for analysis may be the fact
that the subject was or was not independent previously before
the stroke. However, this was not included due to the huge
discrepancy in the answers given (n of yes <0.01%). Also,
the fact that there are characteristics with a predictive value
that was not collected in the initial sample (as economic sta-
tus, comorbidities, cognitive status, or education level) may
also limit the analysis, since only predominantly known fac-
tors with a possible relationship with poststroke functionality
and independence were used.
These findings thus contribute to help planning other
studies hypothesizing that clinical services, environments,
and cultural contexts between countries may alter the
chances of achieving poststroke independence. Therefore,
identify the particularities of each healthcare system, how
they work with the reintegration in the community, and what
strategies are used for achieving poststroke patient’s indepen-
dence across different regions and countries should be specif-
ically investigated in the future.
Data Availability
The data for this study was provided by the IST3 collabora-
tive group and is available at University of Edinburgh
DataShare: https://datashare.ed.ac.uk/handle/10283/1931.
Additional Points
Highlights. (i) This study developed two models with fair pre-
dictive power for poststroke independence at 6 and 18
months based on simple and easy to collect clinical variables.
(ii) We found age, gender, severity, stroke subtype, interven-
tion with Rt-PA, living alone before stroke, and ability to
raise arm and to walk as important predictors for indepen-
dence for poststroke subjects at 18 months, which predictive
models are sparse in the literature. (ii) Poland and Sweden
demonstrate better chances for achieving independence in
the predictive models at 6 compared to the UK. Poland also
have at 18 months. Italy demonstrated worse outcomes at 6
and 18 months. Research is needed to understand character-
istics of healthcare systems that may potentiate this outcome
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